{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:18:45Z","timestamp":1772000325581,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.rvsc.2021.01.017","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T18:20:55Z","timestamp":1611858055000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Danofloxacin pharmacokinetics and tissue residues in Bilgorajska geese"],"prefix":"10.1016","volume":"136","author":[{"given":"Irene","family":"Sartini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"\u0141ebkowska-Wieruszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Lisowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amnart","family":"Poapolathep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2021.01.017_bb0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jvp.12853","article-title":"Comparative pharmacokinetics and bioavailability of marbofloxacin in geese (Anser Anser domesticus) after two sites of intramuscular administrations","volume":"43","author":"Abo-EL-Sooud","year":"2020","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0010","unstructured":"Anonymous, 2012. Guideline on Bioanalytical Method Validation. EMEA\/CHMP\/EWP\/192217\/2009. EMA Committee for Medicinal Products for Human Use (CHMP) Rev. 1 Corr. 2** http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf. Accessed 10 Sept 2020, 44 (July 2011). 2012; 1\u201323: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf%5Cnhttp:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/includes\/document\/document_detail.jsp?webContentId=WC500109686&mid=WC0b01ac058009a3dc."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0015","series-title":"Guideline on Determination of Withdrawal Periods for Edible Tissues","author":"Anonymous","year":"2018"},{"key":"10.1016\/j.rvsc.2021.01.017_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2885.1996.tb00001.x","article-title":"Fluoroquinolones in animal health","volume":"19","author":"Brown","year":"1996","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/AAC.42.1.83","article-title":"Comparison of the efficacies of three fluoroquinolone antimicrobial agents, given as continuous or pulsed-water medication, against Escherichia coli infection in chickens","volume":"42","author":"Charleston","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0034-5288(93)90130-8","article-title":"In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importance","volume":"54","author":"Cooper","year":"1993","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/jvp.12737","article-title":"Pharmacokinetics and bioavailability of danofloxacin in chukar partridge (Alectoris chukar) following intravenous, intramuscular, subcutaneous, and oral administrations","volume":"42","author":"Corum","year":"2019","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/00071668.2013.871502","article-title":"Comparative pharmacokinetics of danofloxacin in common pheasants, Guinea fowls and Japanese quails after intravenous and oral administration","volume":"55","author":"Dimitrova","year":"2014","journal-title":"Br. Poult. Sci."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0045","first-page":"377","article-title":"DNA gyrase, topoisomerase IV, and the 4-quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0050","series-title":"Commission Regulation (EU) No 37\/2010 of 22 December 2009 on Pharmacologically Active Substances and Their Classification Regarding Maximum Residue Limits in Food-stuffs of Animal Origin","first-page":"1","volume":"15","author":"European Commission","year":"2010"},{"key":"10.1016\/j.rvsc.2021.01.017_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/0307945021000071641","article-title":"Apparent eradication of Mycoplasma synoviae in broiler breeders subjected to intensive antibiotic treatment direct to control Escherichia coli","volume":"32","author":"Fiorentin","year":"2003","journal-title":"Avian Pathol."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0060","series-title":"Pharmacokinetic and Pharmacodynamic Data Analysis \u2013 Concepts and Applications","author":"Gabrielsson","year":"2016"},{"key":"10.1016\/j.rvsc.2021.01.017_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1099-0801(200004)14:2<89::AID-BMC931>3.0.CO;2-N","article-title":"Development of a method for the determination of danofloxacin in plasma by HPLC with fluorescence detection","volume":"14","author":"Garcia","year":"2000","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00071660903147416","article-title":"Disposition kinetics and tissue residues of danofloxacin in Muscovy ducks","volume":"50","author":"Goudah","year":"2009","journal-title":"Br. Poult. Sci."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0034-5288(18)31146-9","article-title":"In vitro- evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens","volume":"46","author":"Hannan","year":"1989","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0080","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1128\/AAC.41.9.2037","article-title":"Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones","volume":"41","author":"Hannan","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s11259-006-3400-7","article-title":"Pharmacokinetic\u2013pharmacodynamic modelling of danofloxacin in turkeys","volume":"30","author":"Haritova","year":"2006","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1647\/2011-032","article-title":"Comparative pharmacokinetics of enrofloxacin, danofloxacin, and marbofloxacin after intravenous and oral administration in Japanese quail (Coturnix coturnix japonica)","volume":"27","author":"Haritova","year":"2013","journal-title":"J. Avian. Med. Surg."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2885.1993.tb00292.x","article-title":"A comparison of the efficacy of danofloxacin and tylosin in the control of Mycoplasma gallisepticum infection in broiler chicks","volume":"16","author":"Jordan","year":"1993","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1081\/BIP-100101013","article-title":"Why are pharmacokinetic data summarized by arithmetic means?","volume":"10","author":"Julious","year":"2000","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mri.2017.12.021","article-title":"Robust and efficient pharmacokinetic parameter non-linear least squares estimation for dynamic contrast enhanced MRI of the prostate","volume":"48","author":"Kargar","year":"2018","journal-title":"Magn. Reason. Imag."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2885.1999.00217.x","article-title":"Comparative study of the plasma pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens","volume":"22","author":"Knoll","year":"1999","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/jf00038a012","article-title":"Residue depletion studies on danofloxacin in the chicken","volume":"42","author":"Lynch","year":"1994","journal-title":"J. Agric. Food Chern."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0120","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2307\/1591679","article-title":"Efficacy of danofloxacin and tylosin in the control of mycoplasmosis in chicks infected with tylosin-susceptible or tylosin-resistant field isolates of Mycoplasma gallisepticum","volume":"37","author":"Migaki","year":"1993","journal-title":"Avian Dis."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0125","first-page":"26","article-title":"Duck and geese production around the world","volume":"20","author":"Pingel","year":"2004","journal-title":"World Polit."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12879-016-1470-x","article-title":"Na\u00efve pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis","volume":"16","author":"Pouplin","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2885.1990.tb00758.x","article-title":"Statistical analysis of pharmacokinetic data","volume":"13","author":"Powers","year":"1990","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0140","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2307\/1591556","article-title":"In vitro susceptibility of avian Eschericia coli and Pasteurella multocida to danofloxacin and five other antimicrobials","volume":"36","author":"Raemdonck","year":"1992","journal-title":"Avian Dis."},{"key":"10.1016\/j.rvsc.2021.01.017_bib227","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.rvsc.2019.11.008","article-title":"Pharmacokinetic and tissue analyses of levofloxacin in sheep (Ovis aries Linnaeus) after multiple-dose administration.","volume":"128","author":"Sartini,","year":"2020","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jvp.12893","article-title":"Pharmacokinetics of acetaminophen after intravenous and oral administration in fasted and fed Labrador Retriever dogs","volume":"44","author":"Sartini","year":"2021","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2021.01.017_bib226","first-page":"1","article-title":"Concentrations in plasma and selected tissues of marbofloxacin after oral and intravenous administration in Bilgorajska geese (Anser anser domesticus).","volume":"22","author":"Sartini,","year":"2020","journal-title":"N. Z. Vet. J."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1647\/2018-366","article-title":"Population pharmacokinetics of danofloxacin after single intramuscular dose administration in California Brown pelicans (Pelecanus occidentalis californicus)","volume":"33","author":"Schmitt","year":"2019","journal-title":"J. Avian. Med. Surg."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0165","first-page":"113","article-title":"Pharmacokinetic study of enrofloxacin in Tianfu geese","volume":"24","author":"Shi","year":"2014","journal-title":"J. Anim. Plant Sci."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0170","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.3382\/ps.2012-02310","article-title":"Mycoplasma infection of ducks and geese","volume":"91","author":"Stipkovits","year":"2012","journal-title":"Poult. Sci."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jvp.12714","article-title":"Pharmacokinetics of florfenicol and thiamphenicol in ducks","volume":"42","author":"Tikhomirov","year":"2018","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0180","first-page":"1","article-title":"Pharmacokinetics of florfenicol and thiamphenicol after single oral and intravenous, as well as multiple oral administrations to geese","volume":"12","author":"Tikhomirov","year":"2020","journal-title":"Br. Poult. Sci."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1090-0233(02)00271-X","article-title":"Antibiotic treatment of animals \u2013 a different approach to rational dosing","volume":"165","author":"Toutain","year":"2003","journal-title":"Vet. J."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0190","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2885.2004.00600.x","article-title":"Plasma terminal half-life","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0195","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2885.2004.00604.x","article-title":"Bioavailability and its assessment","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0034-5288(02)00039-5","article-title":"The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics","volume":"73","author":"Toutain","year":"2002","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-199958002-00006","article-title":"Pharmacokinetics and pharmacodynamics of fluoroquinolones","volume":"58","author":"Turnidge","year":"1999","journal-title":"Drugs."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1751-0813.2000.tb10528.x","article-title":"The use of fluoroquinolones for companion animal antimicrobial therapy","volume":"78","author":"Walker","year":"2000","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0215","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jvp.12162","article-title":"Estimating danofloxacin withdrawal time in broiler chickens based on physiologically based pharmacokinetics modeling","volume":"38","author":"Yang","year":"2015","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2885.2010.01223.x","article-title":"Plasma and tissue pharmacokinetics of danofloxacin in healthy and in experimentally infected chickens with Pasteurella multocida","volume":"34","author":"Zeng","year":"2010","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.rvsc.2021.01.017_bb0225","article-title":"Determination of the mutant selection window and evaluation of the killing of Mycoplasma gallisepticum by danofloxacin, doxycycline, tilmicosin, tylvalosin and valnemulin","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528821000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528821000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:21:12Z","timestamp":1758514872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528821000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":45,"alternative-id":["S0034528821000291"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2021.01.017","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danofloxacin pharmacokinetics and tissue residues in Bilgorajska geese","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2021.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}